[1]孙鹏,郭克淼.肠道菌群介导骨质疏松症发生发展机制的研究进展[J].中医正骨,2024,36(12):59-62.
点击复制

肠道菌群介导骨质疏松症发生发展机制的研究进展()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第36卷
期数:
2024年12期
页码:
59-62
栏目:
综述
出版日期:
2024-12-20

文章信息/Info

作者:
孙鹏郭克淼
澧县中医医院,湖南 澧县 415500
关键词:
胃肠道微生物群 骨质疏松 免疫调节 激素代谢 营养吸收 综述
摘要:
骨质疏松症(osteoporosis,OP)的防治工作需要以其发生发展机制为指导,但目前OP的发生发展机制尚未完全明确。多项研究结果表明,肠道菌群与OP的发生发展存在密切联系。本文对肠道菌群的组成结构及其与机体的关系进行了概述,并从免疫调节、激素代谢和营养吸收三方面就肠道菌群介导OP发生发展机制的研究进展进行了综述,以期为OP的防治提供参考。

参考文献/References:

[1] MA S,QIN J,HAO Y,et al.Structural and functional changes of gut microbiota in ovariectomized rats and their correlations with altered bone mass[J].Aging(Albany NY),2020,12(11):10736-10753.
[2] CORNELISSEN D,DE KUNDER S,SI L,et al.Interventions to improve adherence to anti-osteoporosis medications:an updated systematic review[J].Osteoporos Int,2020,31(9):1645-1669.
[3] FAN Z,LI X,ZHANG X,et al.Comparison of OSTA,FRAX and BMI for predicting postmenopausal osteoporosis in a Han population in Beijing:a cross sectional study[J].Clin Interv Aging,2020,15:1171-1180.
[4] AIBAR-ALMAZÁN A,VOLTES-MARTÍNEZ A,CASTELLOTE-CABALLERO Y,et.al.Current status of the diagnosis and management of osteoporosis[J].Int J Mol Sci,2022,23(16):9465.
[5] KITAURA H,KIMURA K,ISHIDA M,et al.Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo[J].Clin Dev Immunol,2013:181849.
[6] OHLSSON C,NIGRO G,BONECA I G,et al.Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling[J].Cell Immunol,2017,317:55-58.
[7] ZHANG Y W,CAO M M,LI Y J,et al.A narrative review of the moderating effects and repercussion of exercise intervention on osteoporosis:ingenious involvement of gut microbiota and its metabolites[J].J Transl Med,2022,20(1):490.
[8] SONG Z,LI S,LI R.An investigation into the correlation of intestinal flora with obesity and gestational diabetes mellitus[J].Comput Math Methods Med,2022:5677073.
[9] WANG J,DONG P,ZHENG S,et al.Advances in gut microbiome in metabonomics perspective:based on bibliometrics methods and visualization analysis[J].Front Cell Infect Microbiol,2023,13:1196967.
[10] CAMPBELL C,KANDALGAONKAR M R,GOLONKA R M,et al.Crosstalk between gut microbiota and host immunity:impact on inflammation and immunotherapy[J].Biomedicines,2023,11(2):294.
[11] PEDROZA MATUTE S,IYAVOO S.Exploring the gut microbiota:lifestyle choices,disease associations,and personal genomics[J].Front Nutr,2023,10:1225120.
[12] SPENCER S P,FRAGIADAKIS G K,SONNENBURG J L.Pursuing human-relevant gut microbiota-immune interactions[J].Immunity,2019,51(2):225-239.
[13] SASSO J M,AMMAR R M,TENCHOV R,et al.Gut microbiome-brain alliance:a landscape view into mental and gastrointestinal health and disorders[J].ACS Chem Neurosci,2023,14(10):1717-1763.
[14] CAMPBELL C,KANDALGAONKAR M R,GOLONKA R M,et al.Crosstalk between gut microbiota and host immunity:impact on inflammation and immunotherapy[J].Biomedicines,2023,11(2):294.
[15] ZHOU B,YUAN Y,ZHANG S,et al.Intestinal flora and disease mutually shape the regional immune system in the intestinal tract[J].Front Immunol,2020,11:575.
[16] WANG C,LI Q,REN J.Microbiota-immune interaction in the pathogenesis of gut-derived infection[J].Front Immunol,2019,10:1873.
[17] GUO M,LIU H,YU Y,et al.Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure[J].Gut Microbes,2023,15(1):2190304.
[18] HAYS K E,PFAFFINGER J M,RYZNAR R.The interplay between gut microbiota,short-chain fatty acids,and implications for host health and disease[J].Gut Microbes,2024,16(1):2393270.
[19] CHEN Y,CUI W,LI X,et al.Interaction between commensal bacteria,immune response and the intestinal barrier in inflammatory bowel disease[J].Front Immunol,2021,12:761981.
[20] RINNINELLA E,RAOUL P,CINTONI M,et al.What is the healthy gut microbiota composition?A changing ecosystem across age,environment,diet,and diseases[J].Microorga-nisms,2019,7(1):14.
[21] SONG M,CHAN A T,SUN J.Influence of the gut microbiome,diet,and environment on risk of colorectal cancer[J].Gastroenterology,2020,158(2):322-340.
[22] LIU Z,LI N,DANG Q,et al.Exploring the roles of intestinal flora in enhanced recovery after surgery[J].iScience,2023,26(2):105959.
[23] KIHL P,KRYCH L,DENG L,et al.Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination[J].PLoS One,2022,17(4):e0266719.
[24] YUAN X,CHANG C,CHEN X,et al.Emerging trends and focus of human gastrointestinal microbiome research from 2010-2021:a visualized study[J].J Transl Med,2021,19(1):327.
[25] IBRAHIM I,SYAMALA S,AYARIGA J A,et al.Modulatory effect of gut microbiota on the gut-brain,gut-bone axes,and the impact of cannabinoids[J].Metabolites,2022,12(12):1247.
[26] ZHOU D,PAN Q,XIN F Z,et al.Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier[J].World J Gastroenterol,2017,23(1):60-75.
[27] LI C,PI G,LI F.The role of intestinal flora in the regulation of bone homeostasis[J].Front Cell Infect Microbiol,2021,11:579323.
[28] YUAN S,SHEN J.Bacteroides vulgatus diminishes colonic microbiota dysbiosis ameliorating lumbar bone loss in ovariectomized mice[J].Bone,2021,142:115710.
[29] LYU Z,HU Y,GUO Y,et al.Modulation of bone remodeling by the gut microbiota:a new therapy for osteoporosis[J].Bone Res,2023,11(1):31.
[30] LEE C S,KIM J Y,KIM B K,et al.Lactobacillus-fermented milk products attenuate bone loss in an experimental rat model of ovariectomy-induced post-menopausal primary osteoporosis[J].J Appl Microbiol,2021,130(6):2041-2062.
[31] YAN J, HERZOG J W, TSANG K,et al.Gut microbiota induce IGF-1 and promote bone formation and growth[J].Proc Natl Acad Sci U S A,2016,113(47):E7554-E7563.
[32] LU L,LI J,LIU L,et al.Grape seed extract prevents oestrogen deficiency-induced bone loss by modulating the gut microbiota and metabolites[J].Microb Biotechnol,2024,17(6):e14485.
[33] ZEIBICH L,KOEBELE S V,BERNAUD V E,et al.Surgical menopause and estrogen therapy modulate the gut microbiota,obesity markers,and spatial memory in rats[J].Front Cell Infect Microbiol,2021,11:702628.
[34] LI J Y,YU M,PAL S,et.al.Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota[J].J Clin Invest,2020,130(4):1767-1781.
[35] YU M,MALIK TYAGI A,LI J Y,et al.PTH induces bone loss via microbial-dependent expansion of intestinal TNF+ T cells and Th17 cells[J].Nat Commun,2020,11(1):468.
[36] BILEZIKIAN J P,FORMENTI A M,ADLER R A,et al.Vitamin D:dosing,levels,form,and route of administration:does one approach fit all?[J].Rev Endocr Metab Disord,2021,22(4):1201-1218.
[37] SUN J,ZHANG Y G.Vitamin D receptor influences intestinal barriers in health and disease[J].Cells,2022,11(7):1129.
[38] QIN C,XIE Y,WANG Y,et al.Impact of lactobacillus casei BL23 on the host transcriptome,growth and disease resis-tance in larval zebrafish[J].Front Physiol,2018,9:1245.
[39] GIUSTINA A,DI FILIPPO L,ALLORA A,et al.Vitamin D and malabsorptive gastrointestinal conditions:a bidirectional relationship?[J].Rev Endocr Metab Disord,2023,24(2):121-138.
[40] DE SIRE A,DE SIRE R,CURCI C,et al.Role of dietary supplements and probiotics in modulating microbiota and bone health:the gut-bone axis[J].Cells,2022,11(4):743.

相似文献/References:

[1]刘磊,万春友,全先辉,等.锁定钢板内固定结合肱骨头植骨重建治疗 肱骨近端Neer三、四部分骨折[J].中医正骨,2015,27(10):52.
[2]徐伟锋,叶健,吴连国.强骨饮对骨质疏松性股骨颈骨折患者全髋关节置换术后 血清骨代谢生化指标和骨密度的影响[J].中医正骨,2015,27(02):12.
 XU Weifeng,YE Jian,WU Lianguo.Effect of Qianggu Yin(强骨饮,QGY)on serum bone metabolism indexes and bone density after total hip arthroplasty in patients with osteoporotic femoral neck fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):12.
[3]龚江浩.股骨近端防旋髓内钉联合抗骨质疏松药物治疗 不稳定型老年股骨转子间骨折的临床观察[J].中医正骨,2015,27(04):29.
 GONG Jianghao.A combination therapy of proximal femoral nail antirotation and anti-osteoporotic drugs for the treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):29.
[4]李冠慧,李灿东,李西海,等.雌激素调控绝经后骨质疏松症骨吸收-骨形成 耦联失衡的机制[J].中医正骨,2016,28(02):36.
[5]费国芳,费红良,王金法.两种内固定方法治疗老年不稳定性股骨转子间骨折的对比研究[J].中医正骨,2016,28(05):9.
 FEI Guofang,FEI Hongliang,WANG Jinfa.Comparison of two kinds of internal fixation for treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(12):9.
[6]陈思凯,邢金明.骨水泥强化椎弓根螺钉内固定治疗老年胸腰椎压缩性骨折[J].中医正骨,2016,28(05):35.
[7]孙鹏,谭磊,阎乾,等.人工肱骨头置换术治疗老年肱骨近端Neer三、四部分骨折[J].中医正骨,2016,28(05):43.
[8]王博,吴鹏,史晓林.强骨饮对去卵巢骨质疏松大鼠骨显微结构的影响[J].中医正骨,2016,28(07):6.
 WANG Bo,WU Peng,SHI Xiaolin.A retrospective trial of postural reduction combined with percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(12):6.
[9]冯建军,邹浩,朱海燕,等.槲皮素对去卵巢大鼠血清骨钙素和股骨Ⅰ型胶原蛋白水平的影响[J].中医正骨,2016,28(07):10.
 FENG Jianjun,ZOU Hao,ZHU Haiyan,et al.Leverage bone grafting and pedicle screw internal fixation through posterior approach for treatment of thoracolumbar fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(12):10.
[10]王吉利,万雷,张志海,等.抑制Dickkopf-1和Sclerostin表达对人成骨肉瘤细胞MG63骨代谢调节相关蛋白表达水平的影响[J].中医正骨,2016,28(09):13.
 WANG Jili,WAN Lei,ZHANG Zhihai,et al.Effect of suppression of Dickkopf-1 and Sclerostin expression on bone metabolism regulatory protein expression levels in human osteosarcoma MG63 cells[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(12):13.

备注/Memo

备注/Memo:
通讯作者:郭克淼 E-mail:190225846@qq.com
更新日期/Last Update: 1900-01-01